STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 3] Accelerate Diagnostics, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Gilbert E. Nathan has filed a Form 3 (Initial Statement of Beneficial Ownership) following his appointment as Director at Accelerate Diagnostics (AXDX). The filing, dated June 28, 2025, discloses Nathan's beneficial ownership position as of April 10, 2025.

Key details from the filing:

  • Nathan currently holds no securities (derivative or non-derivative) beneficially owned in the company
  • The filing confirms his position as Director but indicates no other roles such as Officer or 10% Owner
  • This is an individual filing, not a joint/group submission
  • Business address is listed as 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714

This Form 3 filing is a standard regulatory requirement for new directors under Section 16(a) of the Securities Exchange Act of 1934, establishing a baseline for future ownership reporting.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
NATHAN GILBERT E

(Last) (First) (Middle)
C/O ACCELERATE DIAGNOSTICS, INC.
3950 S. COUNTRY CLUB ROAD, SUITE 470

(Street)
TUCSON AZ 85714

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/10/2025
3. Issuer Name and Ticker or Trading Symbol
Accelerate Diagnostics, Inc [ AXDX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ Gilbert Nathan 06/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the new director appointed to AXDX's board in April 2025?

Gilbert E. Nathan was appointed as a Director of Accelerate Diagnostics (AXDX) effective April 10, 2025, as indicated in the Form 3 filing.

Does Gilbert Nathan own any shares of AXDX stock upon appointment?

According to the Form 3 filing, Gilbert Nathan owns no securities of AXDX beneficially, either directly or indirectly, at the time of his appointment as Director.

What is Gilbert Nathan's role at AXDX as of April 2025?

Gilbert Nathan serves as a Director at Accelerate Diagnostics (AXDX). The Form 3 indicates he is not an officer or 10% owner, but solely holds the position of Director.

When did Gilbert Nathan file his initial Form 3 for AXDX?

Gilbert Nathan filed his Form 3 (Initial Statement of Beneficial Ownership) on June 25, 2025, as evidenced by the signature date on the filing, reporting his beneficial ownership following his appointment as Director on April 10, 2025.
Accelerate Diagnostics Inc

NASDAQ:AXDX

AXDX Rankings

AXDX Latest News

AXDX Latest SEC Filings

AXDX Stock Data

3.49M
15.63M
Analytical Laboratory Instrument Manufacturing
Laboratory Analytical Instruments
Link
US
TUCSON